IS5996A - Use of cholesterol-lowering agent - Google Patents

Use of cholesterol-lowering agent

Info

Publication number
IS5996A
IS5996A IS5996A IS5996A IS5996A IS 5996 A IS5996 A IS 5996A IS 5996 A IS5996 A IS 5996A IS 5996 A IS5996 A IS 5996A IS 5996 A IS5996 A IS 5996A
Authority
IS
Iceland
Prior art keywords
cholesterol
lowering agent
lowering
agent
Prior art date
Application number
IS5996A
Other languages
Icelandic (is)
Inventor
Raza Ali
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315084&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9902590.0A external-priority patent/GB9902590D0/en
Priority claimed from GBGB9921062.7A external-priority patent/GB9921062D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of IS5996A publication Critical patent/IS5996A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
IS5996A 1999-02-06 2001-07-10 Use of cholesterol-lowering agent IS5996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902590.0A GB9902590D0 (en) 1999-02-06 1999-02-06 Use of cholesterol-lowering agent
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent
PCT/GB2000/000285 WO2000045819A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent

Publications (1)

Publication Number Publication Date
IS5996A true IS5996A (en) 2001-07-10

Family

ID=26315084

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5996A IS5996A (en) 1999-02-06 2001-07-10 Use of cholesterol-lowering agent

Country Status (22)

Country Link
EP (1) EP1150679A1 (en)
JP (2) JP2002536333A (en)
KR (1) KR100699287B1 (en)
CN (1) CN1347320A (en)
AR (1) AR022462A1 (en)
AU (1) AU769897B2 (en)
BR (1) BR0007991A (en)
CA (1) CA2358641A1 (en)
CZ (1) CZ20012631A3 (en)
EE (1) EE04659B1 (en)
HK (1) HK1040924A1 (en)
HU (1) HUP0105019A3 (en)
ID (1) ID30131A (en)
IL (1) IL144662A0 (en)
IS (1) IS5996A (en)
MY (1) MY136382A (en)
NO (1) NO319827B1 (en)
NZ (1) NZ512681A (en)
PL (1) PL349137A1 (en)
SK (1) SK11112001A3 (en)
TR (1) TR200102236T2 (en)
WO (1) WO2000045819A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
GB0003305D0 (en) 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
SE0103509D0 (en) * 2001-10-19 2001-10-19 Astrazeneca Ab Rosuvastatin in pre-demented states
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
WO2007142581A1 (en) * 2006-06-07 2007-12-13 Astrazeneca Ab Combination product for the treatment or prevention of dyslipidaemia
US8436028B2 (en) 2007-06-20 2013-05-07 Merck Sharp & Dohme Corp CETP inhibitors derived from benzoxazole arylamides
CA2689525A1 (en) * 2007-06-20 2008-12-24 Merck Sharp & Dohme Corp. Cetp inhibitors derived from benzoxazole arylamides
EP2170058B1 (en) 2007-06-20 2013-07-03 Merck Sharp & Dohme Corp. Cetp inhibitors derived from benzoxazole arylamides
EP2216095A1 (en) * 2009-01-27 2010-08-11 Koninklijke Philips Electronics N.V. Microfluidic device for full blood count

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260446A (en) * 1989-12-22 1993-11-09 Basf Aktiengesellschaft Aminothiazoles
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives

Also Published As

Publication number Publication date
CA2358641A1 (en) 2000-08-10
CZ20012631A3 (en) 2001-10-17
ID30131A (en) 2001-11-08
PL349137A1 (en) 2002-07-01
AR022462A1 (en) 2002-09-04
HUP0105019A2 (en) 2002-05-29
SK11112001A3 (en) 2002-02-05
NO319827B1 (en) 2005-09-19
KR100699287B1 (en) 2007-03-26
MY136382A (en) 2008-09-30
AU2305100A (en) 2000-08-25
EP1150679A1 (en) 2001-11-07
EE200100404A (en) 2002-10-15
AU769897B2 (en) 2004-02-05
EE04659B1 (en) 2006-08-15
JP2002536333A (en) 2002-10-29
KR20010089631A (en) 2001-10-06
WO2000045819A1 (en) 2000-08-10
NZ512681A (en) 2003-12-19
BR0007991A (en) 2001-11-06
TR200102236T2 (en) 2001-12-21
CN1347320A (en) 2002-05-01
NO20013810L (en) 2001-10-03
HK1040924A1 (en) 2002-06-28
HUP0105019A3 (en) 2003-02-28
JP2011137023A (en) 2011-07-14
NO20013810D0 (en) 2001-08-03
IL144662A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
ID26056A (en) DIAPON ONCE USE
ID26389A (en) DIAPON ONCE USE
DK1637127T3 (en) THERAPEUTIC MICROSUM
DE60044131D1 (en) CATHETER
DE60023162D1 (en) STETHOSCOPE
NO20014490L (en) Medical mixtures
NO20022692L (en) Therapeutic agents
DE60018495D1 (en) tampon
DE60018142D1 (en) tampon
DE60027329D1 (en) BIOKOMPATIBLE CATHETER
ID24782A (en) DIAPON ONCE USE
ID25571A (en) DIAPON ONCE USE
DE60025251D1 (en) tampon
ATE348582T1 (en) CONDOM
DE69921599D1 (en) Portable toilet
IS5996A (en) Use of cholesterol-lowering agent
DE60005113D1 (en) Medical hose
IS5814A (en) New pharmaceutical use of NOS agents
EE200100381A (en) New salts of morpholinobenzamide
NO20016301D0 (en) Therapeutic agents
ID30381A (en) USE OF ARILALKANOILPIRIDAZINA
DE29909321U1 (en) tampon
ATA111699A (en) CALCULATION HELP
SE9900671D0 (en) New use
SE9900371D0 (en) New use